Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Jamerson

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|April 16, 2013
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery diseaseGeorge Bakris, Alexandros Briasoulis, Bjorn Dahlof, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
The American Journal of Medicine|April 2, 2013
Systolic blood pressure and cardiovascular outcomes during treatment of hypertensionMichael A Weber, George L Bakris, Allen Hester, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2017
Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD RiskElaine Ku, George Bakris, Kirsten L Johansen, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
American Heart Journal|July 11, 2006
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trialChristopher J Cooper, Timothy P Murphy, Alan Matsumoto, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular events during differing hypertension therapies in patients with diabetesMichael A Weber, George L Bakris, Kenneth Jamerson, et al.
Journal of Cardiac Failure|December 29, 2010
Symptoms characteristic of heart failure among CKD patients without diagnosed heart failureMichael G Shlipak, James P Lash, Wei Yang, et al.
Lancet (London, England)|February 23, 2010
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialGeorge L Bakris, Pantelis A Sarafidis, Matthew R Weir, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|April 16, 2013
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery diseaseGeorge Bakris, Alexandros Briasoulis, Bjorn Dahlof, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
The American Journal of Medicine|April 2, 2013
Systolic blood pressure and cardiovascular outcomes during treatment of hypertensionMichael A Weber, George L Bakris, Allen Hester, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2017
Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD RiskElaine Ku, George Bakris, Kirsten L Johansen, et al.
Blood Pressure|July 7, 2007
Exceptional early blood pressure control rates: the ACCOMPLISH trialKenneth Jamerson, George L Bakris, Björn Dahlöf, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
American Heart Journal|July 11, 2006
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trialChristopher J Cooper, Timothy P Murphy, Alan Matsumoto, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular events during differing hypertension therapies in patients with diabetesMichael A Weber, George L Bakris, Kenneth Jamerson, et al.
Journal of Cardiac Failure|December 29, 2010
Symptoms characteristic of heart failure among CKD patients without diagnosed heart failureMichael G Shlipak, James P Lash, Wei Yang, et al.
Lancet (London, England)|February 23, 2010
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trialGeorge L Bakris, Pantelis A Sarafidis, Matthew R Weir, et al.
Pageof 5